• About Us
    • About AJMC
    • About AJPB
    • About EBO
    • About EBD
  • Publications
    • AJMC
    • AJPB
    • Evidence-Based Diabetes Management
    • Evidence-Based Oncology
    • Supplements
    • Subscribe for FREE
  • AJMC TV
    • Interviews
    • Peer Exchange
  • Interactive
    • Interactive Tools
    • Featured Podcasts
  • Conferences
    • ACC 2013
    • AJMC Live Meeting - Oncology
    • AES2012
    • AHIP 2012
    • AHIP 2012 Fall Forum
    • AHIP Medicare Medicaid
    • AMCP Fall 2012
    • AMCP Spring 2013
    • ADA 2012
    • ADA 2013
    • ASH 2012
    • CHEST 2012
    • Joslin Diabetes Innovation
    • NAMCP 2012
    • NAMCP Spring 2013
    • SCAI 2013
    • ATS 2013
    • ASCO 2013
    • ASHP Summer 2013
    • Sleep 2013
  • News
  • Info for Authors
    • Information for Authors
    • Call for Papers
    • Submit / Track a Manuscript
    • Authorship Forms
    • Information for Reviewers
  • Resource Centers
    • Acute Coronary Syndrome
    • Biosimilars
    • Care Management
    • Diabetes
    • Evidence-Based Oncology
    • Pain
    • Value-Based Cardiology
    • Value-Based Insurance Design
AJMC.com - Managed Markets Network
Advertisement
VIDEOS
Considerations for the Development and Manufacturing of Biosimilars [Presentation]
August 20, 2012, 06:55:43 PM
This content is provided by Amgen.

Divided into 3 sections, this presentation provides insight into the complexities of developing and manufacturing biologics and discusses considerations for the development of biosimilars.

Please click the image below to view the presentation.


Advertisement
Advertisement
Advertisement
About Us | Contact Us | Advertise | Terms & Conditions | Press Room | Copyright HCPLive 2006-2013 | Intellisphere, LLC. All Rights Reserved.
Partner Websites: Pharmacy Times | Targeted Therapies | PainLive | HCPLive | ONCLive